NM_032435.3:c.1552+3319G>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_032435.3(MAP3K21):c.1552+3319G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.338 in 152,008 control chromosomes in the GnomAD database, including 9,598 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.34 ( 9598 hom., cov: 32)
Consequence
MAP3K21
NM_032435.3 intron
NM_032435.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.531
Publications
6 publications found
Genes affected
MAP3K21 (HGNC:29798): (mitogen-activated protein kinase kinase kinase 21) Predicted to enable protein homodimerization activity and protein kinase activity. Predicted to be involved in protein autophosphorylation and signal transduction. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.338 AC: 51379AN: 151890Hom.: 9606 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
51379
AN:
151890
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.338 AC: 51368AN: 152008Hom.: 9598 Cov.: 32 AF XY: 0.340 AC XY: 25237AN XY: 74278 show subpopulations
GnomAD4 genome
AF:
AC:
51368
AN:
152008
Hom.:
Cov.:
32
AF XY:
AC XY:
25237
AN XY:
74278
show subpopulations
African (AFR)
AF:
AC:
7791
AN:
41472
American (AMR)
AF:
AC:
4101
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1256
AN:
3464
East Asian (EAS)
AF:
AC:
2174
AN:
5164
South Asian (SAS)
AF:
AC:
1618
AN:
4812
European-Finnish (FIN)
AF:
AC:
4763
AN:
10556
Middle Eastern (MID)
AF:
AC:
121
AN:
294
European-Non Finnish (NFE)
AF:
AC:
28478
AN:
67946
Other (OTH)
AF:
AC:
705
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1646
3291
4937
6582
8228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1162
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.